Re-expression of DIRAS3 in KRAS Mutant Pancreatic and Ovarian Cancers increases Sensitivity to Autophagy Inhibitors

Authors

Alexandre Rafael Schnell Ribeiro, Houston Baptist UniversityFollow
Gamze B. Elcik, The University of Texas MD Anderson Cancer Center
Zhen Lu MD, The University of Texas MD Anderson Cancer Center
Robert C. Bast, Jr. MD, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

KRAS, DIRAS3, autophagy, chloroquine.

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Ribeiro, Alexandre Rafael Schnell; Elcik, Gamze B.; Lu, Zhen MD; and Bast, Jr., Robert C. MD, "Re-expression of DIRAS3 in KRAS Mutant Pancreatic and Ovarian Cancers increases Sensitivity to Autophagy Inhibitors" (2021). Summer Experience 2021. 69.
https://openworks.mdanderson.org/sumexp21/69